Market Cap

Abcam plc Market Capitalization:

£2.91 Billion

GBP as of Dec. 1, 2022

US$3.58 Billion

business Abcam plc Company Profile

Abcam plc Main Stock Listing

LSE: ABC

Market Capitalization History of Abcam plc

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $622.07 B
Vertex Pharmaceuticals Incorporated $113.24 B
CSL Limited $95.75 B
Regeneron Pharmaceuticals, Inc. $76.33 B
Marinomed Biotech AG $56.13 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $689.42 B
Novo Nordisk $622.07 B
UnitedHealth Group $487.54 B
Johnson & Johnson $353.05 B
AbbVie $301.60 B

Yearly evolution of Abcam plc market cap

Date Market Cap YoY Change
Jan. 1, 2022 £3.17 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +327.04%

$10,000 in March 2024 would now be $42,704 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

Abcam plc Categories

United Kingdom languages Healthcare languages Biotechnology
United Kingdom Healthcare United Kingdom Biotechnology

Stocks & Indices

Abcam plc has the following listings and related stock indices.


Stock: LSE: ABC

Stock: FSX: A8C1

Stock: FSX: A8C3

Stock: OTC: ABCZF

Stock: NASDAQ: ABCM

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.